4D Molecular Therapeutics (FDMT) Amortizatization of Intangibles (2021 - 2026)

4D Molecular Therapeutics (FDMT) has 6 years of Amortizatization of Intangibles data on file, last reported at $1.1 million in Q1 2026.

• Amortizatization of Intangibles for Q1 2026 came in at $1.1 million, down 10.5% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.6 million (up 79.59% YoY), and the FY2025 annual result was $4.7 million, up 130.7% from the prior year.
• Amortizatization of Intangibles declined to $1.1 million in Q1 2026 per FDMT's latest filing, from $1.1 million in the prior quarter.
• Over five years, Amortizatization of Intangibles peaked at $2.8 million in Q4 2022 and troughed at -$2.0 million in Q3 2022.
• A 5-year average of $643647.1 and a median of $513000.0 in 2024 frame the typical range for Amortizatization of Intangibles.
• The sharpest annual moves came in 2022 and 2025: Amortizatization of Intangibles sank 634.47% in 2022, then surged 1140.43% in 2025.
• A 5-year view of Amortizatization of Intangibles shows it stood at $2.8 million in 2022, then tumbled by 85.15% to $411000.0 in 2023, then soared by 67.4% to $688000.0 in 2024, then soared by 66.72% to $1.1 million in 2025, then decreased by 1.13% to $1.1 million in 2026.
• Business Quant data shows FDMT's Amortizatization of Intangibles at $1.1 million in Q1 2026, $1.1 million in Q4 2025, and $1.2 million in Q3 2025.